IP Library Granted Patent US 10,494,681
Granted Patent B2
US 10,494,681 · App. 15/403,926 · Granted Dec 3, 2019

Elite event EE-GM3 and methods and kits for identifying such event in biological samples

Inventors: Justin Thomas Mason (Granger, IA); Leslie James Lettow (Guthrie Center, IA); Mark Alan Eby (Adel, IA); William H. Eby (Panora, IA); Gunter Welz (Wolfenbuttel, DE); Steven Verhaeghe (Grammene-Deinze, BE); Marc De Beuckeleer (Zwijnaarde, BE); Veerle Habex (Gullegem, BE); Jean-Marc Ferrulo (Soucy, FR)
Assignees: BASF AGRICULTURAL SOLUTIONS SEED, US LLC; M.S. TECHNOLOGIES LLC
C12Q1/6895C12N15/8274C12N15/8275C12Q2600/13C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,494,681
App. No.
15/403,926
Granted
Dec 3, 2019
Kind
B2
Abstract

The invention provides specific transgenic soybean plants, plant material and seeds, characterized in that these products harbor a specific herbicide tolerance transformation event at a specific location in the soybean genome. Tools are also provided which allow rapid and unequivocal identification of the event in biological samples.

Claims (8)

1. A kit comprising a first primer comprising at least 17 contiguous nucleotides of SEQ ID No. 2 from nucleotide 1 to nucleotide 1451 and a second primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 2 from nucleotide 1452 to nucleotide 1843, or a first primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 3 from nucleotide 241 to nucleotide 1408 and a second primer comprising at least 17 contiguous nucleotides of SEQ ID No. 3 from nucleotide 1 to nucleotide 240.

2. The kit of claim 1 , wherein said first primer comprises a nucleotide sequence of 17 to 200 contiguous nucleotides of SEQ ID No. 2 from nucleotide 1 to nucleotide 1451 and said second primer comprises 17 to 200 contiguous nucleotides of the complement of SEQ ID No. 2 from nucleotide 1452 to nucleotide 1843, or said first primer comprises a nucleotide sequence of 17 to 200 contiguous nucleotides of the complement of SEQ ID No. 3 from nucleotide 241 to nucleotide 1408 and said second primer comprises 17 to 200 contiguous nucleotides of SEQ ID No. 3 from nucleotide 1 to nucleotide 240.

3. A primer pair comprising a first primer comprising at least 17 contiguous nucleotides of SEQ ID No. 2 from nucleotide 1 to nucleotide 1451 and a second primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 2 from nucleotide 1452 to nucleotide 1843, or a first primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 3 from nucleotide 241 to nucleotide 1408 and a second primer comprising at least 17 contiguous nucleotides, of SEQ ID No. 3 from nucleotide 1 to nucleotide 240.

4. The primer pair of claim 3 , wherein said first primer comprises a nucleotide sequence of 17 to 200 contiguous nucleotides of SEQ ID No. 2 from nucleotide 1 to nucleotide 1451 and said second primer comprises 17 to 200 contiguous nucleotides of the complement of SEQ ID No. 2 from nucleotide 1452 to nucleotide 1843, or said first primer comprises a nucleotide sequence of 17 to 200 contiguous nucleotides of the complement of SEQ ID No. 3 from nucleotide 241 to nucleotide 1408 and said second primer comprises a nucleotide sequence of 17 to 200 contiguous nucleotides of SEQ ID No. 3 from nucleotide 1 to nucleotide 240.

5. A primer pair comprising a first primer comprising the sequence of SEQ ID No. 5 and a second primer comprising the sequence of SEQ ID No. 4, or comprising a first primer comprising the sequence of SEQ ID No. 5 and a second primer comprising the sequence of SEQ ID No. 7.

6. A kit comprising the primer pair of claim 5 .

7. A primer pair comprising a first primer comprising at least 17 contiguous nucleotides of SEQ ID No. 2 from nucleotide 1 to nucleotide 1451 and a second primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 11 from nucleotide 1452 to nucleotide 16638, or a first primer comprising at least 17 contiguous nucleotides of the complement of SEQ ID No. 3 from nucleotide 241 to nucleotide 1408 and a second primer comprising at least 17 contiguous nucleotides of SEQ ID No. 11 from nucleotide 1452 to nucleotide 16638.

8. A kit comprising the primer pair of claim 7 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2019
From: BAYER CROPSCIENCE NV; BAYER CROPSCIENCE SA-NV
To: BASF AGRICULTURAL SOLUTIONS SEED, US LLC
Reel/Frame 049124/0894 →
MERGER Recorded Aug 21, 2017
From: BAYER BIOSCIENCE N.V.
To: BAYER CROPSCIENCE N.V.
Reel/Frame 043619/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: MASON, JUSTIN THOMAS; LETTOW, LESLIE JAMES; EBY, MARK ALAN; EBY, WILLIAM H.; WELZ, GUNTER; VERHAEGHE, STEVEN; DE BEUCKELEER, MARC; HABEX, VEERLE; FERRULO, JEAN-MARC
To: BAYER BIOSCIENCE N.V.; M.S. TECHNOLOGIES LLC
Reel/Frame 043135/0370 →
MERGER Recorded Jul 28, 2017
From: BAYER BIOSCIENCE N.V.
To: BAYER CROPSCIENCE N.V.
Reel/Frame 043373/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2017
From: MASON, JUSTIN THOMAS; LETTOW, LESLIE JAMES; EBY, MARK ALAN; EBY, WILLIAM H.; WELZ, GUNTER; VERHAEGHE, STEVEN; DE BEUCKELEER, MARC; HABEX, VEERLE; FERRULO, JEAN-MARC
To: BAYER BIOSCIENCE N.V.; M.S. TECHNOLOGIES LLC
Reel/Frame 043093/0042 →
Priority Claims (1)
EP 09014564 · Nov 23, 2009 · regional
Continuity (4)
Continuation 13511629
Provisional Application 61367227 · Jul 23, 2010
Provisional Application 61263690 · Nov 23, 2009
Related Publication 20170114419A1 · Apr 27, 2017